Health product recall

JAMP-Doxazosin 4 mg: The uniformity of dosage unit may be out of specification in the affected lot.

Brand(s)
Last updated

Summary

Product
JAMP-Doxazosin 4 mg
Issue
Health products - Product quality
What to do

Consult your health care professional if you have any health concerns.

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot

JAMP-Doxazosin 4 mg

JAMP-Doxazosin 4 mg

DIN 02489953

Tablet

Doxazosin (Doxazosin Mesylate) 4 mg

CDMTC4002A

Issue

The uniformity of dosage unit may be out of specification in the affected lot.

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Retailers

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

JAMP Pharma Corporation

1310 rue Nobel, Boucherville, Québec, J4B 5H3

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-75738

Get notified

Receive notifications for new and updated recalls and alerts by category.

Subscribe